Jun 18, 2021

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

Markets Insider features Starpharma's latest announcement, ..."The results hold significant promise for Viraleze™ – developed by Melbourne-based biopharmaceutical company Starpharma (ASX: SPL) – in the fight against new and emerging variants of SARS-CoV-2, as several countries begin their long-awaited opening of international borders..." Read the full article here. 

 This contains certain forward-looking statements.